tRF ‐3a‐Pro: A Transfer RNA ‐Derived Small RNA as a Novel Biomarker for Diagnosis of Hepatitis B Virus‐Related Hepatocellular Carcinoma
Cell Proliferation · 2025-07 · 58 (7)
DOI: 10.1111/cpr.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 24.02.2025. Verfasst von Jingyi Si und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Hepatitis B virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Xiamen key medical and health project.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the most challenging malignancies of the digestive system. Screening for novel biomarkers and therapeutic targets is a promising strategy to enhance HCC prognosis. Recently, liquid biopsy with circulating nucleic acids as the detection targets has attracted much attention in the field of early screening of tumours. However, the diagnostic value and biological functions of transfer RNA‐derived small RNAs (tsRNAs) in serum, particularly in HCC, remains unknown. In this study, we characterised the expression profile of tsRNAs in hepatitis B virus (HBV)‐related HCC, and confirmed the diagnostic potential of serum tRF‐3a‐Pro. On this basis, we established a diagnostic model that integrates tRF‐3a‐Pro with the classic HCC biomarker alpha‐fetoprotein (AFP) through logistic regression analysis. Besides, both in vivo and in vitro experiments demonstrated that tRF‐3a‐Pro, a highly expressed tsRNA, promotes HCC cell proliferation. These findings suggested that tRF‐3a‐Pro could serve as a novel biomarker for HBV‐related HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Gastroenterology and Hepatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Shanghai Institute of Liver Diseases, Shanghai, China.
ORCID-Profile: Changfeng Zhu
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Xiamen key medical and health project
- Medical Innovation Project of Fujian Province
Zitieren
APA
Si, J., Zou, Y., Gao, Y., Chen, J., Jiang, W., Shen, X., Zhu, C., & Yao, Q. (2025). tRF ‐3a‐Pro: A Transfer RNA ‐Derived Small RNA as a Novel Biomarker for Diagnosis of Hepatitis B Virus‐Related Hepatocellular Carcinoma. Cell Proliferation, 58(7). https://doi.org/10.1111/cpr.70006
Vancouver
Si J, Zou Y, Gao Y, Chen J, Jiang W, Shen X, et al. tRF ‐3a‐Pro: A Transfer RNA ‐Derived Small RNA as a Novel Biomarker for Diagnosis of Hepatitis B Virus‐Related Hepatocellular Carcinoma. Cell Proliferation. 2025;58(7). doi:10.1111/cpr.70006
BibTeX
@article{Si2025,
author = {Si, Jingyi and Zou, Yanting and Gao, Yifan and Chen, Jia and Jiang, Wei and Shen, Xizhong and Zhu, Changfeng and Yao, Qunyan},
title = {tRF ‐3a‐Pro: A Transfer RNA ‐Derived Small RNA as a Novel Biomarker for Diagnosis of Hepatitis B Virus‐Related Hepatocellular Carcinoma},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {7},
doi = {10.1111/cpr.70006}
}
EUVIMED